Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2026American Journal of Hematology

Distinctive Molecular Risk Factors Between MDS and MDS / AML Defined by ICC

View Full Paper
Ask AI
Bookmark
Share

Authors

TZTing‐juan ZhangYZY. X. ZhaoZXZ. Y. Xu

Discussion

Loading...

Member takes

Overview

This analysis reveals distinct molecular risk factors in MDS and MDS/AML, suggesting improved diagnostic precision.

Key Points

  • This research aims to compare the molecular risk factors of MDS and MDS/AML to enhance understanding and classification.
  • Re-evaluated molecular risk factors in patients with MDS and MDS/AML defined by ICC
  • Analyzed key mutations such as TP53 aberrations and FLT3-ITD
  • Developed a new prognostic model called MDS/AML-IPSS-M
  • Identified significant differences in molecular landscapes between MDS and MDS/AML
  • Most risk factors in MDS were not present in MDS/AML
  • Established MDS/AML-IPSS-M improved prognostic discrimination for MDS/AML patients

Cite This Study

Zhang et al. (2026) studied this question.

synapsesocial.com/papers/69cd7a4e5652765b073a7613https://doi.org/10.1002/ajh.70296
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comparative Analysis of ICC and WHO Classifications Reveals Molecular and Clinical Convergence Between AML-MR and MDS/AML.2026 · 2 citations
  2. 2Clinico‐genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification2023 · 15 citations
  3. 3Integration of genomic and clinical variables improves the prediction of myelodysplastic syndromes to acute myeloid leukaemia transformation and prognosis2025 · 2 citations
  4. 4Validation of ICC hierarchical classification in secondary AML2026 · 3 citations
  5. 5ELN vs. IPSS-M in MDS/AML: Which Prognostic System Should Guide Clinical Decision-Making?2026